Ini1 inhibitors are a class of chemical compounds that specifically target and modulate the activity of the Ini1 protein, also known as SNF5 or SMARCB1. Ini1 is a critical component of the SWI/SNF chromatin remodeling complex, which plays a pivotal role in the regulation of gene expression and chromatin structure. The SWI/SNF complex is responsible for ATP-dependent repositioning of nucleosomes along DNA, thus allowing access to transcription factors and other regulatory proteins. Ini1, as part of this complex, is crucial for maintaining proper chromatin dynamics and gene regulation. However, when Ini1 function is dysregulated or lost, it can lead to aberrant gene expression patterns and contribute to various diseases, including cancer.
Ini1 inhibitors are designed to interfere with the activity of Ini1, either by directly binding to Ini1 or by targeting other components of the SWI/SNF complex that are essential for Ini1 function. By inhibiting Ini1, these compounds disrupt the normal chromatin remodeling processes and gene expression patterns associated with Ini1 activity. This modulation of chromatin structure and gene regulation has implications in various biological processes, including development, differentiation, and disease progression. Therefore, the study and development of Ini1 inhibitors hold promise for gaining insights into the molecular mechanisms underlying Ini1-associated pathologies and for exploring avenues.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
This histone deacetylase inhibitor might alter chromatin structure and gene expression patterns, potentially impacting Ini1 expression. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
As an HSP90 inhibitor, this compound could impact the stability and function of Ini1. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
This bromodomain inhibitor might influence chromatin structure and gene expression, potentially impacting Ini1 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
By inhibiting PI3K, this compound could affect signaling pathways involved in cell growth and survival, potentially influencing Ini1 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
As a topoisomerase I inhibitor, this compound might affect DNA replication and transcription, potentially influencing Ini1 expression. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
By inhibiting PARP, this compound could influence DNA repair and gene expression, potentially impacting Ini1. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $61.00 $85.00 | 4 | |
This aurora kinase inhibitor might affect cell cycle progression and gene expression, potentially impacting Ini1 expression. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
As a CDK4/6 inhibitor, this compound could affect cell cycle progression and gene expression, potentially influencing Ini1 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
This HDAC inhibitor might alter chromatin structure and gene expression patterns, potentially impacting Ini1 expression. | ||||||